vidagliptin-tablets-galvus-50mg

vidagliptin-tablets-galvus-50mg

Vildagliptin is a DPP-4 inhibitor approved for the treatment of type 2 diabetes. Glucagon-like peptide-1 (GLP-1) is a hormone that is rapidly released from the intestine after eating. GLP-1 signals to the pancreas to increase insulin release, and reduce glucagon release, after a meal.05-Jul-2021